Summary

fridgeneed27 Users

  • Hypoxia-responsive pullulan-based nanoparticles as erlotinib companies.
Offline Offline
Posts:
0 (0 per day)
Age:
N/A
Date Registered:
2025-07-14, 11:04:46
Local Time:
2025-07-17, 09:17:42
Last Active:
2025-07-14, 14:59:12
Signature:
rved for tissue infill (
 = .211) and the MRI composite score (
 = .099) from 2 years to final review. At final MRI review, 9 grafts (9.1%) had fail